Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Oct 25, 2021 3:16pm
474 Views
Post# 34046570

RE:RE:RE:RE:St- Michaels Hospital

RE:RE:RE:RE:St- Michaels Hospital

Oilminerdeluxe wrote: 4-5 more patients must have had their 3 month check up done by mid- November, right? Correct me if I am wrong. One can at least have hopes that things will turn brighter if a majority of them are healthy. They must have a Q or two left before money becomes tight. Should be additional patients treated by then too. Data is becoming so very important now. 20 cents feels unfair. But I am not smart enough to understand the markets. 


On August 30th we were told 4 additional patients were treated, so those patients were treated before August 30, so end of November, we may get 90 days data on up to 6 additional patients (#s 19,20,21,22,23,24) , as well as 6 months data on (13-18).  A nice data set at up to 12 optimally treated PH2 patients.  All IMO

<< Previous
Bullboard Posts
Next >>